Work

S2037 Guselkumab Is Efficacious and Safe for Moderately-to-Severe Active Ulcerative Colitis: Real-World Data From a Large Tertiary Center

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001135608.54119.0d

Authors: Asher Shafrir, Alex J. Mathew, Jessica Tanouye, Alexandra R. Hannett, Russell Yanofsky, David Choi, Russell D. Cohen, David T. Rubin

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417197366

Cites:

Cited by:

Related to: